In securities litigation, clients draw on our expertise in finance, accounting, economics, and biostatistics along with our knowledge of the competitive and regulatory environments that impact life sciences firms. Attorneys and corporations often retain us when facing government investigations or private litigation to address class certification, evaluate loss causation, and estimate damages. Our experience includes matters related to:
- Announcements of FDA approval decisions
- Publication of clinical trial results
- Accounting treatment of expected penalties for off-label marketing
- Withdrawal of a blockbuster drug from the market for safety reasons
- Value of Pharmacy Benefit Manager contracts in a pharmacy merger